Companies: 10,795·Total market cap: $144.5T
ContraFect Corporation

ContraFect Corporation

CFRXQOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$107
P/E Ratio
52W High$0.0005
52W Low$0.00001
Overview

ContraFect Corporation (CFRXQ) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

CFRXQ · shares outstanding · updated Jun 10, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
521,359 +13.41% YoY Change
FY · as of Dec 31, 2022 · Reported in USD
vs 459,699 in FY 2021
Diluted Shares Outstanding
521,359
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+13.41%
year-over-year
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-10

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+71.4%
2019 → 2022
5-Year CAGRincreasing
+49.6%
2017 → 2022
10-Year CAGR

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2022Latest
Diluted Shares: 521,359
521,359
+13.41%
FY 2021
Diluted Shares: 459,699
459,699
+61.56%
FY 2020
Diluted Shares: 284,544
284,544
+174.81%
FY 2019
Diluted Shares: 103,543
103,543
+8.90%
FY 2018
Diluted Shares: 95,078
95,078
+36.81%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs CFRXQ
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
ContraFect CorporationCFRXQ
ContraFect CorporationYOU
521,359

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

ContraFect Corporation (CFRXQ) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2022, ContraFect Corporation reports 521,359 basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

ContraFect Corporation's basic shares outstanding (521,359) represents currently issued shares. Diluted shares outstanding (521,359) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

ContraFect Corporation's float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

ContraFect Corporation (CFRXQ) shares outstanding history from 2016 to 2022. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

ContraFect Corporation shares outstanding for the fiscal year ending December 31, 2022 were 521,359, a 13.41% increase year-over-year. ContraFect Corporation FY 2022 shares outstanding were 521,359, a +13.41% increase from FY 2021.

ContraFect Corporation is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of — — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

CFRXQ shares outstanding · 4 questions

As of December 31, 2022, ContraFect Corporation (CFRXQ) has approximately 521,359 basic shares outstanding and 521,359 diluted shares outstanding. This represents a +13.41% year-over-year increase from FY 2021 (459,699). The increase may reflect equity compensation issuances or secondary offerings.

CFRXQ shares outstandinghow many shares does CFRXQ haveCFRXQ basic shares 2022CFRXQ diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · ContraFect Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-10